In hepatocellular carcinoma cells, overexpression of SIRT3 facilitated the activation of the JNK signaling pathway, resulting in apoptosis (Zhang & Zhou, 2012); however, low SIRT3 expression is associated with a markedly shorter period of clinical recurrence. Here, SIRT3 is linked to hepatocellular carcinoma.